Results 231 to 240 of about 43,089 (386)
Abstract Aims The EMAIL‐HF trial aims to evaluate whether a digital guideline implementation strategy can increase and accelerate initiation of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors in patients with heart failure (HF). Methods and results EMAIL‐HF is a pragmatic, registry‐based, randomized controlled trial including patients with a ...
Mariam Elmegaard+21 more
wiley +1 more source
Asymptomatic Left Ventricular Hypertrophy Is a Potent Risk Factor for the Development of HFpEF but Not HFrEF: Results of a Retrospective Cohort Study [PDF]
А. Г. Овчинников+3 more
openalex +1 more source
This systematic review identified 24 clinical trials of medical device and surgical interventions for HFpEF, with 16 demonstrating at least safety and feasibility, but little evidence of long‐term benefit. Phenotype‐based responses suggest that certain interventions may benefit specific HFpEF subgroups, yet most trials suffered from heterogeneous ...
Kurdo Araz+5 more
wiley +1 more source
Structural and Hemodynamic Changes of the Right Ventricle in PH-HFpEF [PDF]
Maria Barilli+3 more
openalex +1 more source
A pilot study on DNA methylation changes for non‐invasive molecular diagnostics in heart failure
A liquid biopsy approach integrating the high‐resolution RRBS DNA methylation platform and network‐oriented strategy identified the hypomethylation of CPTA1, CKAP4, SPTB, SYT6, EIF2S2, and RAB11FIP1 genes as useful biomarkers in distinguishing between ischaemic and non‐ischaemic HF aetiologies.
Giuditta Benincasa+7 more
wiley +1 more source
Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients
Patrick Rossignol, João Pedro Ferreira
openalex +1 more source
Does Chronotropic Incompetence in HFpEF Cause or Result From Exercise Intolerance?
Van‐Khue Ton, Gregory D. Lewis
openalex +1 more source